Longitudinal assessments of MRD in high‐risk newly diagnosed transplant‐ineligible multiple myeloma in the BENEFIT study (IFM2020‐05)

ABSTRACT:

SUBMITTER: Corre J 

PROVIDER: S-EPMC13637644 | biostudies-literature | 2026 Oct

REPOSITORIES: biostudies-literature